Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Study Title
A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Teva Identifier
TV1106-IMM-20001 | 2013-004468-69
ClinicalTrials.gov Identifier
NCT02092077
Study Status
Terminated
Trial Condition(s)
Growth Hormone-Deficiency
Interventions
Drug: TV-1106 | Drug: somatropin

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
3 Years to 11 Years
Trial Duration
April 30, 2014 - August 31, 2016
Phase
Phase 2

Study Type

Interventional